1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Lymphocytic: new trials by email Literature Review of Lymphocytic trials Research Report on Lymphocytic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia LMB-2 - Leukemia, Lymphocytic | Phase 2 | Completed | National Cancer Institute (NCI) | 15 | 2004-02-29 | 2018-01-23 |
Bronchiolitis Obliterans Syndrome (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Neoplasms (1)
Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Chronic Disease (1) · Disease Attributes (1) · Graft vs Host Disease (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Lymphatic Diseases (1)
B3(Fv)-PE38KDEL recombinant immunotoxin (1)
National Cancer Institute (NCI) (1)
United States (1)